반응식
[N:1]1[C:5]2[CH:6]=[CH:7][C:8]([C:10]([NH:12][NH2:13])=[O:11])=[CH:9][C:4]=2[NH:3][CH:2]=1.[Cl:14][C:15]1[CH:20]=[C:19]([Cl:21])[CH:18]=[CH:17][C:16]=1[CH2:22][CH2:23][C:24](O)=O>>[Cl:14][C:15]1[CH:20]=[C:19]([Cl:21])[CH:18]=[CH:17][C:16]=1[CH2:22][CH2:23][C:24]1[O:11][C:10]([C:8]2[CH:7]=[CH:6][C:5]3[NH:1][CH:2]=[N:3][C:4]=3[CH:9]=2)=[N:12][N:13]=1참가 물질
3
실험 절차
The compound was synthesized starting from benzimidazol-5-carbohydrazide (176 mg, 1 mmol) and 3-(2,4-dichlorophenyl)propionic acid (220 mg; 1 mmol) as described in method 2;
후처리
- customThe compound was synthesized
출처 및 근거
- ORD 기록
- ord-99c061bbd3854637a63918c0d1e0596c
- 출처 데이터셋
- uspto-grants-2015_11
- 특허 번호
- US09181233B2
연결된 노트
불러오는 중…